Medical inflation is projected at nearly 6% annually, outpacing income growth and pushing lifetime health care costs toward $1 million for many couples.

EBSA said the $1.4 billion returned to plans, participants and beneficiaries represents a slight increase from the $1.384 billion recovered in fiscal year 2024.

Demand for obesity and metabolic therapies is accelerating deal activity as pharma companies shift from blockbuster drugs to platform control.

Global prevalence climbs, boosting demand for insulin, devices and new therapies like Mounjaro and Ozempic.

In-office job postings have surged 21% since 2023, when roughly two-thirds of roles were on-site.

Physician leaders warn that without protections, insurers' new policies could add administrative and financial burdens, threatening patient care.

Sixty-seven percent of remote roles were for mid- to senior-level candidates, compared with just 6% that were entry-level.

About half of physicians reported their patients sought medications through compounding pharmacies or by traveling abroad.